Literature DB >> 8569177

Role of neutrophils and lymphocytes in inhibition of a mouse mammary adenocarcinoma engineered to release IL-2, IL-4, IL-7, IL-10, IFN-alpha, IFN-gamma, and TNF-alpha.

P Musiani1, A Allione, A Modica, P L Lollini, M Giovarelli, F Cavallo, F Belardelli, G Forni, A Modesti.   

Abstract

Impressive inhibition of tumor growth has been observed after transduction of cytokine genes into tumor cells. Secreted cytokines do not affect the proliferation of a tumor directly but activate a host immune reaction strong enough to overcome its oncogenic capacity. However, the reaction mechanisms activated are difficult to interpret; because these mechanisms have been derived from experiments with different tumors, comparisons are hindered. To compare the reactive mechanisms induced by each cytokine, BALB/c mice were challenged with the parental cells of the syngeneic spontaneous mammary adenocarcinoma TSA, or with TSA cells engineered to release IL2, IL4, IL7, IL10, IFN alpha, IFN gamma, and TNF alpha, and the tumor growth area was studied histologically, ultrastructurally, and immunohistochemically. These observations were integrated with data on the growth and rejection patterns of TSA cells in mice depleted of natural killer (NK) cells, granulocytes, CD4+, or CD8+ lymphocytes. The rejection of TSA-IL2 and TSA-TNF alpha cells was associated with the massive presence of neutrophils, that of TSA-IL4 and TSA-IL7 cells with neutrophils and very small areas of colliquative necrosis, and that of TSA-IFN alpha and TSA-IL10 cells with extensive areas of ischemic-coagulative necrosis and some neutrophils. TSA-IFN gamma cells displayed a delay in growth, but were not rejected. Their growth areas comprised necrotic zones of ischemic necrosis devoid of neutrophils. The selective depletion experiments demonstrated that rejection of engineered TSA cells depends on several leukocyte populations. The weight of each population varied with the secreted cytokine, although neutrophils and CD8+ lymphocytes constantly played the major role. Employment of the same tumor line engineered with the genes of different cytokines showed that each cytokine evokes a distinct reaction and that tumor inhibition results from a complex mechanism in which neutrophils and CD8+ lymphocytes and ischemic necrosis are of primary importance.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8569177

Source DB:  PubMed          Journal:  Lab Invest        ISSN: 0023-6837            Impact factor:   5.662


  21 in total

Review 1.  Immunotherapy I: Cyclosine gene transfer strategies.

Authors:  M P Colombo; G Forni
Journal:  Cancer Metastasis Rev       Date:  1996-09       Impact factor: 9.264

Review 2.  Mouse versus Human Neutrophils in Cancer: A Major Knowledge Gap.

Authors:  Evgeniy B Eruslanov; Sunil Singhal; Steven M Albelda
Journal:  Trends Cancer       Date:  2017-01-19

Review 3.  Protumor and antitumor functions of neutrophil granulocytes.

Authors:  Sven Brandau; Claudia A Dumitru; Stephan Lang
Journal:  Semin Immunopathol       Date:  2012-09-25       Impact factor: 9.623

4.  An important role for granulocytes in the thermal regulation of colon tumor growth.

Authors:  Julie R Ostberg; Bradley R Ertel; Julie A Lanphere
Journal:  Immunol Invest       Date:  2005       Impact factor: 3.657

5.  Tumor-infiltrating neutrophils in pancreatic neoplasia.

Authors:  Michelle D Reid; Olca Basturk; Duangpen Thirabanjasak; Ralpha H Hruban; David S Klimstra; Pelin Bagci; Deniz Altinel; Volkan Adsay
Journal:  Mod Pathol       Date:  2011-08-05       Impact factor: 7.842

6.  Inhibition of lung colonisation of a mouse mammary carcinoma by therapeutic vaccination with interferon-alpha gene-transduced tumor cells.

Authors:  I Rossi; G Nicoletti; L Landuzzi; F Frabetti; C De Giovanni; P Nanni; P Musiani; M Ferrantini; F Belardelli; P L Lollini
Journal:  Clin Exp Metastasis       Date:  1998-02       Impact factor: 5.150

7.  Observation of calcium microdomains at the uropod of living morphologically polarized human neutrophils using flash lamp-based fluorescence microscopy.

Authors:  Andrea J Clark; Howard R Petty
Journal:  Cytometry A       Date:  2008-07       Impact factor: 4.355

8.  Targeting GPR30 with G-1: a new therapeutic target for castration-resistant prostate cancer.

Authors:  Hung-Ming Lam; Bin Ouyang; Jing Chen; Jun Ying; Jiang Wang; Chin-Lee Wu; Li Jia; Mario Medvedovic; Robert L Vessella; Shuk-Mei Ho
Journal:  Endocr Relat Cancer       Date:  2014-10-06       Impact factor: 5.678

9.  The universal dynamics of tumor growth.

Authors:  Antonio Brú; Sonia Albertos; José Luis Subiza; José López García-Asenjo; Isabel Brú
Journal:  Biophys J       Date:  2003-11       Impact factor: 4.033

10.  Tumour cell lines HT-29 and FaDu produce proinflammatory cytokines and activate neutrophils in vitro: possible applications for neutrophil-based antitumour treatment.

Authors:  Antonio Brú; Juan-Carlos Souto; Sonia Alcolea; Rosa Antón; Angel Remacha; Mercedes Camacho; Marta Soler; Isabel Brú; Amelia Porres; Luis Vila
Journal:  Mediators Inflamm       Date:  2010-02-11       Impact factor: 4.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.